NewAmsterdam Pharma (NAMS) EBITDA (2023 - 2026)
NewAmsterdam Pharma's EBITDA was -$64.86 million in Q2 2026, compared with -$36.06 million a year earlier.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) EBITDA (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, NewAmsterdam Pharma's EBITDA was -$244.63 million through Jun 30, 2026; for FY2025, it came in at -$226.87 million.
- In earlier years, EBITDA was -$176.4 million in FY2024, -$182.92 million in FY2023, -$3.55 million in FY2022 and -$34.82 million in FY2021.
- Quarterly EBITDA has moved between -$69.39 million (Q1 2025) and -$24.98 million (Q3 2024) over five years.
- Per Business Quant data, NAMS's EBITDA in the three quarters before Q2 2026 was -$58.35 million (Q1 2026), -$65.95 million (Q4 2025) and -$55.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | NewAmsterdam Pharma | 2.43 Bn | -108.81 Mn | - | -44.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -44.12 Mn |
| Jun 30, 2026 | -64.86 Mn |
| Mar 31, 2026 | -58.35 Mn |
| Dec 31, 2025 | -65.95 Mn |
| Sep 30, 2025 | -55.48 Mn |
| Jun 30, 2025 | -36.06 Mn |
| Mar 31, 2025 | -69.39 Mn |
| Dec 31, 2024 | -43.18 Mn |
| Sep 30, 2024 | -24.98 Mn |
| Jun 30, 2024 | -52.56 Mn |
| Mar 31, 2024 | -55.47 Mn |
| Dec 31, 2023 | -51.06 Mn |
| Sep 30, 2023 | -49.54 Mn |
| Jun 30, 2023 | -42.47 Mn |
| Mar 31, 2023 | -39.84 Mn |
API Access
NewAmsterdam Pharma EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();